Results 171 to 180 of about 8,187 (238)

Emergence of carbapenemase KPC-14 in an <i>Escherichia coli</i> isolate: a case report. [PDF]

open access: yesJAC Antimicrob Resist
Fontán García-Rodrigo L   +4 more
europepmc   +1 more source

Reduced Susceptibility to Cefiderocol Among Clinical MCR-1-Producing <i>Escherichia coli</i> Isolates from Tunisia. [PDF]

open access: yesAntibiotics (Basel)
Jaidane N   +12 more
europepmc   +1 more source

Mechanisms involved in cefiderocol resistance in French <i>Pseudomonas aeruginosa</i> clinical strains. [PDF]

open access: yesAntimicrob Agents Chemother
Gauthier E   +9 more
europepmc   +1 more source

Real-World Use of Cefiderocol for Multidrug-Resistant Gram-Negative Infections in Critically Ill ICU Patients: A Single-Center Case Series. [PDF]

open access: yesPathogens
Ritiu SA   +9 more
europepmc   +1 more source

Genomic and structural insights into the in vivo development of cefiderocol resistance in Klebsiella pneumoniae. [PDF]

open access: yesAppl Microbiol Biotechnol
Tristancho-Baró A   +11 more
europepmc   +1 more source

Carbapenemases in Gram-Negative Bacilli: Classification, Detection, Therapeutic Options, and Resistance to Novel Antimicrobials. [PDF]

open access: yesAntibiotics (Basel)
Vulpie S   +7 more
europepmc   +1 more source

Cefiderocol Susceptibility in Japanese Clinical Enterobacterales Isolates and the Effect of IMP-Type Carbapenemases on Resistance. [PDF]

open access: yesAntibiotics (Basel)
Cai M   +7 more
europepmc   +1 more source

Comparative evaluation of the activity of novel β-lactam antibiotics against difficult-to-treat <i>Pseudomonas aeruginosa</i> clinical isolates. [PDF]

open access: yesJAC Antimicrob Resist
Mystakelis H   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy